First-lineGlucophage
Metformin
Biguanide oral hypoglycaemic
First-line oral agent for GDM and pre-existing T2DM in pregnancy.
Oral
First-line for
- Gestational diabetes (when diet/exercise fail)
- Type 2 DM in pregnancy
- PCOS-related anovulation / fertility
Mechanism
Activates AMPK → ↓ hepatic gluconeogenesis, ↑ peripheral insulin sensitivity. Does not cause hypoglycaemia alone.
“GI-LAC”
- GI upset most common SE
- Lactic acidosis (rare, renal)
- Acidosis: hold if eGFR <30
- Combine with insulin if targets not met
Dosing
- Start
- 500 mg OD with food
- Titrate
- ↑ weekly to 500–1000 mg BD–TDS
- Max
- 2,500–3,000 mg/day divided
Contraindications
- AbsoluteeGFR <30 mL/min
- AbsoluteAcute metabolic acidosis, severe sepsis
- CautionPause around iodinated contrast & surgery
Side effects
- Nausea, diarrhoea, abdominal pain
- Metallic taste
- Vit B12 deficiency (long-term)
- Lactic acidosis (rare)
Fetal & maternal notes
- • Crosses placenta — no teratogenicity signal.
- • Long-term follow-up of offspring reassuring (MiG-TOFU).
- • Safe in breastfeeding.
Key interactions
Iodinated contrast
Caution↑ lactic acidosis risk — hold 48 h
Insulin
OKSynergistic — common combination
Alcohol
Caution↑ lactic acidosis
Clinical pearls
- 💡 Start before insulin in GDM unless severe hyperglycaemia.
- 💡 Continue intrapartum; review postpartum at 6 weeks with OGTT.
Content last reviewed: REPLACE_ME (e.g. 2026-07)
Spotted something out of date? See our disclaimer or use Report an Error above.